Preliminary research reveal conolidine may possibly inhibit specific ion channels, lessening neuronal excitability and restricting agony indicators. This system is particularly pertinent in neuropathic soreness, where by irregular signaling brings about persistent irritation. In addition, conolidine seems to impact G protein-coupled receptor (GPCR)